BJ
XLRN

BlackRock Japan’s Acceleron Pharma XLRN Stock Holding History

BlackRock Japan’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-221
Closed -$8K – 1404
2016
Q3 		$8K Buy
221
+127
+135% +$4.21K ﹤0.01% 1230
2016
Q2 		$3K Buy
+94
New +$3.06K ﹤0.01% 1390
2016
Q1 		– Sell
-88
Closed -$4K – 1502
2015
Q4 		$4K Buy
+88
New +$3.17K ﹤0.01% 1346
2014
Q2 		– Sell
-5,082
Closed -$175K – 1432
2014
Q1 		$175K Buy
5,082
+2,134
+72% +$96.3K ﹤0.01% 962
2013
Q4 		$117K Buy
+2,948
New +$71.2K ﹤0.01% 1001

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return